NAD Press Releases

NAD Recommends Alcon Discontinue Certain Claims for Air Optix Aqua Contacts Following Challenge by JJVC

The NAD has recommended that Alcon Laboratories, Inc., discontinue certain comparative superiority claims for the company’s Air Optix Aqua Contact Lenses, following a challenge from Johnson & Johnson Vision Care, Inc. (JJVC), the maker of Acuvue OASYS.

Read More

NAD Refers Talking Rain Beverage Company to FTC After Company Fails to Comply with NAD Recommendations to Modify, Discontinue Certain Advertising Claims

The NAD has referred advertising claims made by Talking Rain Beverage Company to the Federal Trade Commission (FTC) after a compliance review indicated that the company had not complied with the terms of an earlier NAD decision.

Read More

NAD Recommends Cerebral Success Discontinue Certain Claims for SmartX Dietary Supplement

The NAD has recommended that Cerebral Success, maker of the dietary supplement “SmartX,” discontinue a wide range of claims challenged by the Council for Responsible Nutrition (CRN).

Read More

NAD Finds Hill’s Pet Nutrition Violated NAD/NARB Procedures in Outreach Campaign to Bloggers

The National Advertising Division (NAD) has determined that Hill’s Pet Nutrition violated the procedures that govern the advertising industry’s system of self-regulation by seeking to use for promotional purposes decisions reached by the NAD and the National Advertising Review Board (NARB).

Read More

NAD Recommends P&G Discontinue Certain Claims for ‘Olay Sensitive Body Wash’ Following Unilever Challenge

The NAD has recommended that The Procter & Gamble Company, the maker of Olay Sensitive Body Wash, discontinue claims that convey the unsupported message that Dove Sensitive Skin Body Wash, a competing product made Unilever United States, Inc., is “harsh.” Further, NAD recommended that P&G modify claims that Dove Sensitive Skin Body Wash can dry one’s skin over time.

Read More

NAD Recommends Virtua Health System Discontinue Challenged Claims for ‘Quad-Sparing’ Knee Replacement Surgery

The NAD has recommended that Virtua Health System discontinue certain advertising claims for the hospital chain’s minimally invasive, “quad-sparing” knee-replacement surgery.

Read More